Position in SANA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$779,707
+$207,463 QoQ
Shares Held
223,412
+12.4% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,525,193 across 328 Biotechnology names. SANA ranks #154 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $779,707 | 223,412 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $572,244 | 198,696 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $770,906 | 189,412 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $694,756 | 195,706 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $554,962 | 203,283 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $305,985 | 182,134 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $281,623 | 172,775 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $714,638 | 171,788 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $993,190 | 181,903 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,568,470 | 156,847 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $620,094 | 151,984 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $580,956 | 150,118 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $910,986 | 152,850 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $466,275 | 142,592 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $546,411 | 138,332 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $825,372 | 137,562 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $836,022 | 130,019 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $749,148 | 90,696 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,318,555 | 85,178 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,883,775 | 83,649 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $468,714 | 23,841 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $702,234 | 20,981 | Shares | Sole | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||